Equivocal and weakly positive hybrid capture 2 tests in women aged 50 and older

Diagnostic Cytopathology

Volumn 40, Issue 8, 2012, Pages 708-712

  De Vries, Christiaan Erik ^a   Shen, Rulong ^a   Stephens, Julie ^b   Suarez, Adrian A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

age; cervical intraepithelial neoplasia; human papilloma virus; hybrid capture 2

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER GRADING; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

AGED; AGED, 80 AND OVER; CYTODIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84864286021     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21710     Document Type: Article

References (19)

1. Smith RA, Cokkinides V, Brooks D, Brawley OW,. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010; 60: 99-119.
2. American College of Obstetricians and Gynecologists,. Clinical management guidelines for obstetricians-gynecologists: Cervical cancer screening. Obstet Gynecol 2009; 151: 1409-1420.
3. Abati A, Jaffurs W, Wilder AM,. Squamous atypia in the atrophic cervical vaginal smear: A new look at an old problem. Cancer 1998; 84: 218-225.
4. Cibas ES, Browne TJ, Mantel Bassichis MH, Lee KR,. Enlarged squamous cell nuclei in cervical cytologic specimens from perimenopausal women ("PM cells"). Am J Clin Pathol 2005; 124: 58-61.
5. Jovanovic AS, McLaghlin CM, Shen L, Welch WR, Crum CP,. Postmenopausal squamous atypia: A spectrum including "pseudo-koilocytosis." Mod Pathol 1995; 8: 408-412.
6. Johnston EI, Logani S,. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: Lessons learned from human Papillomavirus DNA testing. Cancer 2007; 111: 160-165.
7. Assay Manual. Digene: HC2 HPV DNA Test. Gaithersburg, MD: 2007. p 1-51.
8. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papilloma virus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-474.
9. Jacobs MV, Walboomers JM, Snijders PJ, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 221-227.
10. Cuzik J, Beverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81: 554-558.
11. Jarboe EA, Venkat P, Hirsch MS, Cibas ES, Crum CP, Garner EIO,. A weakly positive human papilloma virus hybrid capture II result correlates with a significant lower risk of cervical intraepithelial neoplasia 2, 3 after atypical squamous cells of undetermined significance cytology. J Low Genit Tract Dis 2010; 14: 174-178.
12. Keating JT, Wang HH,. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer Cytopathol 2001; 93: 100-105.
13. Eltoum IA, Chhieng DC, Roberson J, McMillon D, Partridge EE,. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer Cytopathol 2005; 105: 194-198.
14. Zhao CH, Zhao S, Heider A, Austin RM,. Significance of high risk papilloma virus DNA detection in women 50 years and older with squamous cell Papanicolaou test abnormalities. Arch Pathol Lab Med 2010; 134: 1130-1135.
15. Sargent A, Bailey A, Turner A, et al. Optimal threshold for a positive Hybrid Capture 2 test for detection of human papillomavirus: Data from the ARTSTIC trial. J Clin Microbiol 2010; 48: 554-558.
16. Ordi J, Alonso I, Torné A, et al. Human papillomavirus load in Hybrid Capture II assay: Does increasing the cutoff improve the test? Gynecol Oncol 2005; 99: 313-319.
17. Knoepp SM, Kuebler DL, Wilbur DC,. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: A cytologic/histologic review of 191 cases. Diagn Mol Pathol 2007; 16: 125-129.
18. Knoepp SM, Kuebler DL, Wilbur DC,. Correlation between hybrid capture II high-risk human papilloma virus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results. Cancer Cytopathol 2010; 118: 209-217.
19. Qureshi MN, Bolick D, Ringer PJ, Spangler FL, Zimmerman G,. HPV testing in liquid cytology specimens. Comparison of analytic sensitivity and specificity for in situ hybridization and chemiluminescent nucleic acid testing. Acta Cytol 2005; 49: 120-126.